Von Willebrand Factor Multimer Patterns in Pregnancy-Induced Hypertension

Summary

Microangiopathy and disseminated platelet aggregation have been reported in thrombotic thrombocytopenic purpura (TIP) and pregnancy-induced hypertension (PIH). Since unusually large von Willebrand factor (vWF) multimers have been implicated in the evolvement of TTP, we analyzed factor VIII/vWF parameters in patients with PIH. Mean vWF: Ag level was significantly higher in 27 patients with PIH as compared to 20 matched healthy pregnant women (358 ± 160 u/dl vs. 274 ± 125 u/dl, p < 0.05). Moreover, plasma vWF: Ag levels and the ratio of vWF: Ag to factor VIII were found to be linearly correlated to the severity of PIH. In contrast, no significant differences in mean levels of factor VIII and ristocetin cofactor were observed between these groups. Crossed immunoelectrophoresis of vWF revealed a higher incidence of a pre-peak and an increased migration index in the PIH group as compared to the control group (60% vs. 44% and 1.27 ± 0.26 vs. 1.19 ± 0.18, p < 0.01 respectively). Analysis of plasma vWF multimer patterns by 1.4% agarose electrophoresis in 0.1% SDS revealed excessive amounts of large, medium and small size multimers in the PIH patients. Conceivably, the quantitative changes in vWF multimers reflect endothelial injury and may play a role in the microangiopathy observed in PIH.

Keywords

Pregnancy-induced hypertension - Factor VIII - von Willebrand factor - Fetal growth retardation

• References

• 1 Worley RJ. Pathophysiology of pregnancy induced hypertension. Clin Obstet Gynecol 1984; 27: 821-835
• 2 Sheppard BL, Bonnar J. The ultrastructure of the human placenta in pregnancy complicated by fetal growth retardation. J Obstet Gynecol Br Commonw 1976; 83: 948-959
• 3 Byrnes JJ, Moake JL. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: evolving concepts of pathogenesis and therapy. Clin Haematol 1986; 15: 413-442
• 4 Redman CW J, Denson KW E, Beilin L. Factor VIII consumption in pre-eclampsia. Lancet 1977; 2: 1249-1252
• 5 Thornton CA, Bonnar J. Factor VIII related antigen and factor VIII coagulant activity in normal and pre-eclamptic pregnancy. J Obstet Gynecol Br Commonw 1977; 84: 919-923
• 6 Moake JL, Rudi CK, Troll JN, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL, Deykin D. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 1982; 307: 1432-1435
• 7 Devue SJ, O'Shaughnessy R. Clinical manifestations and diagnosis of pregnancy induced hypertension. Clin Obstet Gynecol 1984; 27: 836-853
• 8 Hardisty RM, Macpherson JC. A one stage factor VIII assay and its use on venous and capillary plasma. Thromb Diath Haemorrh 1962; 7: 215-219
• 9 Seligsohn U, Zivelin A, Perez Ch, Modan M. Detection of hemophilia A carriers by replicate factor VIII activity and antigenicity determinations. Br J Haematol 1979; 42: 433-439
• 10 MacFarlane PE, Stibbe J, Kirby FP, Zucker MB, Grant RA, Macpherson JC. A method for assaying von Willebrand Factor (ristocetin cofactor). Thromb Diath Haemorrh 1975; 34: 306-310
• 11 Ruggeri ZM, Mannucci PM, Lombardi R, Federici AB, Zimmerman TS. Multimeric composition of factor VIII/von Willebrand Factor following administration of DDAVP: Implication for pathophysiology and therapy of von Willebrand's disease subtypes. Blood 1982; 59: 1271-1278
• 12 Enayat MS, Hill FG H. Analysis of the complexity of the multimeric structure of factor VIII related antigen/von Willebrand protein using a modified electrophoretic technique. J Clin Pathol 1983; 36: 915-919
• 13 Scholtes MC W, Gerresten G, Haak HL. The factor VIII ratio in normal and pathological pregnancies. Eur J Obstet Gynecol Reprod Biol 1983; 16: 89-95
• 14 Miller CH, Hilgarten MW, Lestrange RC, McLaughlin GW. Factor VIII-related antigen pre-peak on crossed immunoelectrophoresis; a non-random phenomenon. Thromb Res 1982; 25: 101-107
• 15 Stel HV, Sakariassen KS, de Groot PG, van Mourik JA, Sixma JJ. Von Willebrand factor in the vessel wall mediates platelet adherence. Blood 1985; 65: 85-90
• 16 Turitto VT, Weiss HJ, Zimmerman TS, Sussman II. Factor VHI/von Willebrand factor in subendothelium mediates platelet adhesion. Blood 1985; 65: 823-831
• 17 Redman CW G, Bonnar J, Beilin LJ. Early platelet consumption in pre-eclampsia. Br Med J 1978; 1: 467-469
• 18 Calvin S, Corrigan J, Weinstein L, Jeter M. Factor VIII: von Willebrand factor patterns in the plasma of patients with preeclampsia. Am J Perinatol 1988; 5: 29-32
• 19 Asada Y, Sumiyoshi A, Hayashi T, Suzumiya J, Kaketani K. Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen. Thromb Res 1985; 38: 469-479
• 20 Moake JL, Mcpherson PD. Von Willebrand factor multimeric abnormalities in a large series of patients with single episode and intermittent thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. Blood 1988; 72 suppl (Suppl. 01) 372A
• 21 Harrison RL, McKee PA. Estrogen stimulates von Willebrand factor production by cultured endothelial cells. Blood 1984; 63: 657-665
• 22 Davidson JM, Gilmore EA, Durr J, Robertson GL, Lindheimer MD. Altered osmotic thresholds for vasopressin secretion and thirst in human pregnancy. Am J Physiol 1984; 246: 105-109
• 23 Kelton JG, Moore J, Santos A, Sheridan D. The detection of a platelet-agglutination factor in thrombotic thrombocytopenic purpura. Ann Intern Med 1984; 101: 589-593